| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
|
FIGURE 4. Immunohistochemistry of tumor sections with an antifactor VIII antibody. Microvessel numbers in 200x field are 29.9 ± 2.5 in control tumor (A) and 8.30 ± 0.8 in tumor treated with thalidomide (B) (P < 0.0001).
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
